O-(2-[18F]fluoroethyl)-L-tyrosine-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trial

Journal:
The Lancet Oncology
Published:
Affiliations:
34
Authors:
46
Institutions Authors Share
University Medical Center Freiburg, Germany
10.500000
10.500000
0.38
University Hospital Tübingen (UKT), Uni Tübingen, Germany
1.500000
0.05
University Hospital Aachen (UKA), RWTH Aachen, Germany
1.333333
0.05
University of Duisburg-Essen (UDE), Germany
1.000000
0.04
TUM University Hospital Klinikum rechts der Isar (MRI), Germany
1.000000
0.04
Städtisches Klinikum Karlsruhe gGmbH, Germany
1.000000
0.04
Kantonsspital Graubünden, Switzerland
1.000000
0.04
Philipps University of Marburg (Uni Marburg), Germany
1.000000
0.04
DKTK Partner Site Freiburg, Germany
1.000000
0.04
University Medicine Rostock, Germany
1.000000
0.04
University Medical Centre Mannheim (UMM) at Medical Faculty Mannheim, Uni Heidelberg, Germany
0.666667
0.02
Technical University of Munich (TUM), Germany
0.500000
0.02
Dessau Medical Center, Germany
0.500000
0.02
Brandenburg Medical School - Theodor Fontane (MHB), Germany
0.500000
0.02
Kliniken Maria Hilf GmbH, Germany
0.500000
0.02
Comprehensive Cancer Center Erlangen-EMN (CCC), FAU, Germany
0.500000
0.02
Ortenau Klinikum Offenburg-Kehl, Germany
0.500000
0.02
Bavarian Cancer Research Center (BZKF), Germany
0.500000
0.02
University Hospital of Munich (KUM), LMU, Germany
0.500000
0.02
University Children's Hospital Basel (UKBB), Switzerland
0.500000
0.02
University Hospital of Erlangen, FAU, Germany
0.500000
0.02
University Hospital Magdeburg (UKMD), OVGU, Germany
0.500000
0.02
Medical University of Graz (Med Uni Graz), Austria
0.500000
0.02
Center for Integrated Oncology Aachen Bonn Köln Düsseldorf (CIO), Germany
0.333333
0.01
Jülich Research Centre (FZJ), Germany
0.333333
0.01
DKFZ-Hector Cancer Institute at the University Medical Centre Mannheim, Germany
0.333333
0.01